The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Speciality Medicines IPO
Speciality Medicines
SMEListed

Speciality Medicines IPO

Bidding 20-24 Mar 2026, price band ₹117–124, lot 1000 shares.

0%
listing gain
OverviewSubscriptionAllotment

IPO timeline

  1. Issue open date
    20 Mar 2026
  2. Issue close date
    24 Mar 2026
  3. UPI mandate deadline
    24 Mar 2026
  4. Allotment finalization
    25 Mar 2026
  5. Refund initiation
    27 Mar 2026
  6. Share credit
    27 Mar 2026
  7. Listing date
    30 Mar 2026
  8. Mandate end date
    9 Apr 2026
  9. Lock-in end date for anchor investors (50%)
    24 Apr 2026
  10. Lock-in end date for anchor investors (remaining)
    23 Jun 2026

Speciality Medicines IPO Allotment Status

Allotment date:25 Mar 2026
Registrar:Skyline Financial Services Private Ltd
  1. Open the registrar's allotment page from the link below.
  2. Select Speciality Medicines from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Skyline Financial Services(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:27 Mar 2026
Shares credited to demat:27 Mar 2026
Listing:30 Mar 2026
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)1.8753.5%
bHNI2.540.0%
sHNI0.62100%
QIBs96.24🔥-
Retail0.83100%
Total2.26-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 24 March'26 04:44PM

Quick Stats

Issue Size:29cr
Lot Size:1000 shares
Min Investment (2 lots):₹2,48,000
P/E Ratio:9.27

Price Band

₹117–124
per share

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Speciality Medicines Limited sells medicines used to treat serious and long-term health conditions. These include diseases like cancer, immune-related disorders, neurological conditions, and rare illnesses. The company offers a wide range of medicines in different forms such as tablets, capsules, syrups, injections, and inhalers.It runs its business in two main ways. First, it gets medicines manufactured through third-party manufacturers and supplies them to customers, including in international markets. Second, it sources medicines from manufacturers and markets and distributes them to buyers. The company earns its revenue mainly by selling these pharmaceutical products. Overall, its focus is on providing specialised medicines that are used for complex treatments across different therapeutic areas. 

Strengths

  • Focuses on speciality medicines for complex and chronic diseases.
  • Diverse product portfolio across multiple therapeutic areas.
  • A wide range of dosage forms enhances product reach.
  • Dual business model of manufacturing and distribution.
  • Presence in international markets through a distribution network.

Risks

  • Dependence on third-party manufacturers for product supply.
  • High reliance on a few key customers for revenue.
  • Strict quality requirements may lead to order cancellations.
  • Ongoing legal proceedings involving a promoter.
  • Exposure to supply disruptions and price volatility.

Speciality Medicines IPO – Frequently Asked Questions

  • The price band for the Speciality Medicines IPO is set at ₹117 to ₹124 per share.
  • The Speciality Medicines IPO opens on March 20, 2026 and closes on March 24, 2026.
  • The tentative listing date for the Speciality Medicines IPO is March 30, 2026.
  • The Speciality Medicines IPO listed on March 30, 2026 with a listing gain of 0% over its issue price.
  • The Speciality Medicines IPO allotment date is March 25, 2026. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Skyline Financial Services Private Ltd. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Speciality Medicines IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Speciality Medicines, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Speciality Medicines IPO is 1000 shares. As an SME IPO, individual investors must apply for at least 2 lots (i.e., 2000 shares), which costs ₹2,48,000 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent SME listings

  • Antala IndustriesListed 11 Nov 2026
    -20%
  • Vedant Poly FabsListed 9 Nov 2026
    0%
  • Johnsoncab ElectricalsListed 6 Nov 2026
    +19.25%
  • HGS (India)Listed 6 Nov 2026
    +33.33%
  • Vectras EnproconListed 6 Nov 2026
    +0.95%
  • Maxwell Engineering SolutionsListed 6 Nov 2026
    +90%

All IPOs that opened in March 2026